Multiple resections and survival of recurrent glioblastoma patients in the temozolomide era

Alicia Ortega, J. Manuel Sarmiento, Diana Ly, Miriam A Nuno, Debraj Mukherjee, Keith L. Black, Chirag G. Patil

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Glioblastoma (GBM) is the most prevalent and aggressive primary brain tumor in adults for which recurrence is inevitable and surgical resection is often recommended. We investigated the relationship between multiple tumor resections and overall survival (OS) in adult glioblastoma patients who received adjuvant radiotherapy and temozolomide following initial surgery. We retrospectively reviewed the records of all newly diagnosed adult GBM patients with tumor recurrence at our institution from March 2003 to October 2012. Kaplan-Meier survival estimates and multivariate analysis using Cox's proportional hazards model were utilized to evaluate the impact of multiple resections on OS. A total of 202 GBM patients were analyzed; 83 (41.1%), 94 (46.5%), and 25 (12.4%) patients underwent one, two, and three or more total resections, respectively. Patients who underwent multiple resections were significantly younger (p < 0.0001) and had higher perioperative Karnofsky Performance Status scores (p < 0.0001) than single resection patients. The median OS in months was 21.1, 25.5, and 29.0 for patients who had one, two, and three or more resections, respectively (Wilcoxon p = 0.03). In a confounder-adjusted multivariate model, patients with multiple resections did not have significantly improved survival (p = 0.55). Older age was strongly associated with poorer OS (hazard ratio 1.34, p < 0.0001). Age at diagnosis was the only predictor of survival for recurrent GBM patients. After adjusting for age at diagnosis, multiple resections were not an independent predictor of OS in our glioblastoma cohort treated in the temozolomide era.

Original languageEnglish (US)
Pages (from-to)105-111
Number of pages7
JournalJournal of Clinical Neuroscience
Volume24
DOIs
StatePublished - Feb 1 2016
Externally publishedYes

Fingerprint

temozolomide
Glioblastoma
Survival
Karnofsky Performance Status
Recurrence
Adjuvant Radiotherapy
Kaplan-Meier Estimate
Survival Analysis

Keywords

  • Glioblastoma
  • Multiple resections
  • Overall survival
  • Recurrence

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology
  • Physiology (medical)

Cite this

Multiple resections and survival of recurrent glioblastoma patients in the temozolomide era. / Ortega, Alicia; Sarmiento, J. Manuel; Ly, Diana; Nuno, Miriam A; Mukherjee, Debraj; Black, Keith L.; Patil, Chirag G.

In: Journal of Clinical Neuroscience, Vol. 24, 01.02.2016, p. 105-111.

Research output: Contribution to journalArticle

Ortega, Alicia ; Sarmiento, J. Manuel ; Ly, Diana ; Nuno, Miriam A ; Mukherjee, Debraj ; Black, Keith L. ; Patil, Chirag G. / Multiple resections and survival of recurrent glioblastoma patients in the temozolomide era. In: Journal of Clinical Neuroscience. 2016 ; Vol. 24. pp. 105-111.
@article{3f403813844c488c88d8a024551f794c,
title = "Multiple resections and survival of recurrent glioblastoma patients in the temozolomide era",
abstract = "Glioblastoma (GBM) is the most prevalent and aggressive primary brain tumor in adults for which recurrence is inevitable and surgical resection is often recommended. We investigated the relationship between multiple tumor resections and overall survival (OS) in adult glioblastoma patients who received adjuvant radiotherapy and temozolomide following initial surgery. We retrospectively reviewed the records of all newly diagnosed adult GBM patients with tumor recurrence at our institution from March 2003 to October 2012. Kaplan-Meier survival estimates and multivariate analysis using Cox's proportional hazards model were utilized to evaluate the impact of multiple resections on OS. A total of 202 GBM patients were analyzed; 83 (41.1{\%}), 94 (46.5{\%}), and 25 (12.4{\%}) patients underwent one, two, and three or more total resections, respectively. Patients who underwent multiple resections were significantly younger (p < 0.0001) and had higher perioperative Karnofsky Performance Status scores (p < 0.0001) than single resection patients. The median OS in months was 21.1, 25.5, and 29.0 for patients who had one, two, and three or more resections, respectively (Wilcoxon p = 0.03). In a confounder-adjusted multivariate model, patients with multiple resections did not have significantly improved survival (p = 0.55). Older age was strongly associated with poorer OS (hazard ratio 1.34, p < 0.0001). Age at diagnosis was the only predictor of survival for recurrent GBM patients. After adjusting for age at diagnosis, multiple resections were not an independent predictor of OS in our glioblastoma cohort treated in the temozolomide era.",
keywords = "Glioblastoma, Multiple resections, Overall survival, Recurrence",
author = "Alicia Ortega and Sarmiento, {J. Manuel} and Diana Ly and Nuno, {Miriam A} and Debraj Mukherjee and Black, {Keith L.} and Patil, {Chirag G.}",
year = "2016",
month = "2",
day = "1",
doi = "10.1016/j.jocn.2015.05.047",
language = "English (US)",
volume = "24",
pages = "105--111",
journal = "Journal of Clinical Neuroscience",
issn = "0967-5868",
publisher = "Churchill Livingstone",

}

TY - JOUR

T1 - Multiple resections and survival of recurrent glioblastoma patients in the temozolomide era

AU - Ortega, Alicia

AU - Sarmiento, J. Manuel

AU - Ly, Diana

AU - Nuno, Miriam A

AU - Mukherjee, Debraj

AU - Black, Keith L.

AU - Patil, Chirag G.

PY - 2016/2/1

Y1 - 2016/2/1

N2 - Glioblastoma (GBM) is the most prevalent and aggressive primary brain tumor in adults for which recurrence is inevitable and surgical resection is often recommended. We investigated the relationship between multiple tumor resections and overall survival (OS) in adult glioblastoma patients who received adjuvant radiotherapy and temozolomide following initial surgery. We retrospectively reviewed the records of all newly diagnosed adult GBM patients with tumor recurrence at our institution from March 2003 to October 2012. Kaplan-Meier survival estimates and multivariate analysis using Cox's proportional hazards model were utilized to evaluate the impact of multiple resections on OS. A total of 202 GBM patients were analyzed; 83 (41.1%), 94 (46.5%), and 25 (12.4%) patients underwent one, two, and three or more total resections, respectively. Patients who underwent multiple resections were significantly younger (p < 0.0001) and had higher perioperative Karnofsky Performance Status scores (p < 0.0001) than single resection patients. The median OS in months was 21.1, 25.5, and 29.0 for patients who had one, two, and three or more resections, respectively (Wilcoxon p = 0.03). In a confounder-adjusted multivariate model, patients with multiple resections did not have significantly improved survival (p = 0.55). Older age was strongly associated with poorer OS (hazard ratio 1.34, p < 0.0001). Age at diagnosis was the only predictor of survival for recurrent GBM patients. After adjusting for age at diagnosis, multiple resections were not an independent predictor of OS in our glioblastoma cohort treated in the temozolomide era.

AB - Glioblastoma (GBM) is the most prevalent and aggressive primary brain tumor in adults for which recurrence is inevitable and surgical resection is often recommended. We investigated the relationship between multiple tumor resections and overall survival (OS) in adult glioblastoma patients who received adjuvant radiotherapy and temozolomide following initial surgery. We retrospectively reviewed the records of all newly diagnosed adult GBM patients with tumor recurrence at our institution from March 2003 to October 2012. Kaplan-Meier survival estimates and multivariate analysis using Cox's proportional hazards model were utilized to evaluate the impact of multiple resections on OS. A total of 202 GBM patients were analyzed; 83 (41.1%), 94 (46.5%), and 25 (12.4%) patients underwent one, two, and three or more total resections, respectively. Patients who underwent multiple resections were significantly younger (p < 0.0001) and had higher perioperative Karnofsky Performance Status scores (p < 0.0001) than single resection patients. The median OS in months was 21.1, 25.5, and 29.0 for patients who had one, two, and three or more resections, respectively (Wilcoxon p = 0.03). In a confounder-adjusted multivariate model, patients with multiple resections did not have significantly improved survival (p = 0.55). Older age was strongly associated with poorer OS (hazard ratio 1.34, p < 0.0001). Age at diagnosis was the only predictor of survival for recurrent GBM patients. After adjusting for age at diagnosis, multiple resections were not an independent predictor of OS in our glioblastoma cohort treated in the temozolomide era.

KW - Glioblastoma

KW - Multiple resections

KW - Overall survival

KW - Recurrence

UR - http://www.scopus.com/inward/record.url?scp=84954077776&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84954077776&partnerID=8YFLogxK

U2 - 10.1016/j.jocn.2015.05.047

DO - 10.1016/j.jocn.2015.05.047

M3 - Article

VL - 24

SP - 105

EP - 111

JO - Journal of Clinical Neuroscience

JF - Journal of Clinical Neuroscience

SN - 0967-5868

ER -